Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Cooking the books
View:
Post by Stockdeals on Mar 01, 2021 7:16pm

Cooking the books

It took them 8 months to cook the books.  Wow! Buy! Buy! Buy!
Comment by Captainblk on Mar 01, 2021 7:20pm
oh look, another "career" basher
Comment by Stockdeals on Mar 01, 2021 7:27pm
Not a career basher, i just know a pile of turd when I see it.  
Comment by Glta613 on Mar 01, 2021 7:31pm
Any proof they cooked the books or just a nothing burger? You shorts are pathetic, it's beyond obvious. Look at the gains in only 2 days trading. Winning.
Comment by KILOFINAL on Mar 01, 2021 7:35pm
yeah...that explains why you're so desperate posting on a bullboard for a stock you don't own. LOL I cut and paste all your posts and forward them to the company so their aware...thanks! 
Comment by Stockdeals on Mar 01, 2021 7:47pm
Ok pumper...As you sit here as the wolf in sheep's clothing, waiting to take away all these millennials weekly allowance. Lol
Comment by Glta613 on Mar 01, 2021 7:49pm
I simply asked for proof for what you stated. If you have none just say so. 0.15 by end of week just watch and learn.
Comment by Captainblk on Mar 01, 2021 7:54pm
well at least youre self aware
Claritas Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities